天灵灵地灵灵,kmph不要清零查看全文
黄野仁2021-02-10 21:52
$KemPharm(KMPH)$
tak武田制药,通过收购Shire得到NEW RIVER的ADHD药物Vyvanse
corium,GPC子公司,kmph里程碑付款提供者,专门负责合作kmph
kmph老板T博士,Vyvanse和kp415开发者查看全文
$KemPharm(KMPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-23-004793 Act: 34 Size: 77 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-23-004784 Act: 34 Size: 211 KB 网页链接
$KemPharm(KMPH)$ PREC14A Preliminary proxy statements, contested solicitations Accession Number: 0001437749-23-004742 Act: 34 Size: 868 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001437749-23-004450 Act: 34 Size: 350 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-23-001701 Act: 34 Size: 237 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, item 8.01 Accession Number: 0001437749-23-001447 Act: 34 Size: 166 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-001059 Size: 4 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-001060 Size: 5 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-000919 Size: 5 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-000915 Size: 5 KB 网页链接